Chiasma's Series B Round

Chiasma raised a round of funding on September 08, 2005.

Chiasma (NASDAQ: CHMA) is a biopharmaceutical company dedicated to improving the lives of patients with rare diseases by developing and commercializing oral medications that were previously available …

Articles about Chiasma's Series B Round: